|
|
|
市場調查報告書
全球海洋生物技術市場
Marine Biotechnology
|
本報告已在2012年05月14日停止出版。
更改為出版
Marine Biotechnology
出版日期 : 2012年04月
商品編碼: 240149
本報告書為海洋生物科技的全球市場之調査、產業概要、地區市場概要、業界的最近動態、相關企業、將來展望等，概述如下。
第1章 導論、調査方法、以及產品定義
第2章 產業動態
- 市場評分卡
- 現在以及將來分析
- 動向與課題
- 不景氣對生物科技市場造成的影響
- 醫療、食品、化粧品部門
- 研究開發投資的不足
- 海洋生態學
- 海洋塗料市場概要
第3章 海洋生物科技 - 概要
- 前兆
- 微生物為何重要？
- 歷史要約
- 定義
- 海洋生物科技產品來源
- 海洋生物科技產品種類
- 海洋生物物質
- 海洋生物活性物質
- 其他海洋產品與程序
- 最終用途分析
- 海洋生物由來產品分析
- 研究開發活動
第4章 各地區市場概要
第5章 產品導入・技術革新
第6章 近年業界活動
第7章 過去企業活動
第8章 主要的市場企業
第9章 世界市場前景
競爭簡介
Abstract
This report analyzes the Global markets for Marine Biotechnology in US$
Million by the following product segments- Marine Biomaterials, Marine
Bioactive Substances, and Others. The Major End-Use Applications analyzed are
Industrial Products, Health Care/Biotechnology, Consumer Products, Public
Services & Infrastructure, and Others. Annual estimates and forecasts are
provided for the period 2009 through 2015. Also, a six-year historic analysis
is provided for this market. The report profiles 85 companies including many
key and niche players such as Aker BioMarine ASA, CP Kelco US, Inc., Cyanotech
Corp., Elan Corp, FMC Corp., FMC Biopolymers AS, GlycoMar Ltd., Integrin
Advanced Biosystems, International Specialty Products Inc., Lonza Group Ltd.,
MariCal, Marinova, Martek Biosciences Corp., Mera Pharmaceuticals Inc., New
England Biolabs Inc., PharmaMar S.A, PML Applications Ltd., Primex Ltd.,
Prolume Ltd., Sea Run Holdings Inc., and Tequesta Marine Biosciences. Market
data and analytics are derived from primary and secondary research. Company
profiles are mostly extracted from URL research and reported select online
sources.
Table of Contents
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
- Study Reliability And Reporting Limitations 1
- Disclaimers 2
- Data Interpretation & Reporting Level 3
- Quantitative Techniques & Analytics 3
- Product Definitions and Scope of Study 3
- By Product Segment 3
- Biomaterials 3
- Bioactive Substances 3
- Others 3
- By End-Use Application 4
- Industrial Products 4
- Health Care/Biotechnology 4
- Consumer Products 4
- Public Services And Infrastructure 4
- Others 4
2. INDUSTRY DYNAMICS 5
- Market Scorecard 5
- Current & Future Analysis 5
- By Product Segment 5
- By End-Use Segment 5
- Trends and Issues 6
- Recession Impacts Biotechnology Market 6
- Medical, Food and Cosmetic Sectors Garner Research Dollars 6
- Lack of R&D Investment in the Marine Biotech Industry 6
- Preserving Marine Ecology: A Prime Concern 7
- A Glance at Marine Coatings Market 7
3. MARINE BIOTECHNOLOGY - AN OVERVIEW 8
- A Curtain Raiser 8
- Why are Microorganisms Crucial? 8
- Brief History 9
- Definition 9
- Sources of Marine Biotech Products 10
- Key Marine Sources and Products 10
- Select Marine-Derived Products 10
- Flora and Fauna 11
- Protista 11
- Bacteria 11
- Fungi 11
- Types of Marine Biotech Products 11
- Marine Biomaterials 12
- Marine Adhesives 12
- Marine Bioactive Substances 12
- Select Biological Materials and Chemicals Extracted from Marine
Organisms 13
- Select Companies Involved in Supplying Reagents or Nutritional Products
from Marine Organisms 15
- Enzymes 15
- Haloperoxidase Enzymes 15
- Thermostable DNA-Modifying Enzymes 15
- Other Marine Products and Processes 15
- Marine Biomass 15
- Marine Bio-Process 16
- Certain Significant Bio-Processes and their Application 16
- End-Use Analysis 16
- Definition 16
- Industrial Products 16
- Health Care/Biotechnology 17
- Consumer Products 17
- Public Services and Infrastructure 17
- Others 17
- Overview 17
- Application Areas 18
- Foods 18
- Nutraceuticals 18
- Medicine 18
- Cosmetics 18
- Research Tools 19
- Processing Technologies 19
- New Energy Sources 19
- Agriculture 19
- Industrial 19
- Food Safety 20
- Environmental Management 20
- Bioremediation 20
- Marine Biosurfactants 21
- Select Biosurfactants Produced from Marine Microorganisms 21
- Aquaculture and Marine Biotechnology 21
- Select Companies Carrying Out Genetic Enhancement or Aquaculture
Breeding Programs 22
- Industrial Applications 22
- Healthcare 22
- Select Marine Diterpenes and Their Biological Activity 23
- Select Players Involved in Biosensor/Diagnostic Activity 23
- Select Marine-Based Drugs 23
- Cytosar-U 23
- Prialt 23
- Yondelis 24
- Bryostatin 24
- Dehydrodidemnin B 24
- Pseudopterosins 24
- Bio-Prospecting 24
- Select Companies Involved in Bioprospecting and Bioscreening for Novel
Marine-Based Compounds 25
- Consumer Products 25
- Select Macroalgal Materials and Their Application in Cosmetic
Industry 25
- Public Services and Infrastructure 26
- Others 26
- Agriculture 26
- Mining 26
- An Insight into Select Marine-Origin Products 26
- Agar 26
- Major Seaweeds Used for Extracting Agar and Agarose 27
- Alginate 27
- Astaxanthin 28
- Select Producers of Natural and Synthetic Astaxanthin 28
- Carrageenan 28
- Chitin and Chitosan 29
- Chitin 29
- End-use Applications 29
- Chitosan 30
- Select Industrial Applications of Chitosan 31
- Collagen 31
- Salmon Calcitonin 32
- Research and Development Activity 32
- Medical 32
- Research on Natural Products 32
- Tackling Biotoxins 33
- Controlling Oil Spill Damage 33
- Preventing Biofouling 33
- Antifouling Coatings 33
- Coral Reefs Offer Abundant Opportunities 33
4. REGIONAL MARKET OVERVIEW 35
- United States 35
- Market Outlook 35
- Overview 35
- Aquaculture Biotechnology 35
- Rest of World 35
- Market Outlook 35
- Australia 36
- Canada 36
- China 36
- Europe 37
- United Kingdom 37
- Norway 38
- Overview 38
- Market Participants 38
- Industrial Applications 38
- Pharmaceuticals 39
- Latin America 39
- India 39
- Marine Environment Offers Abundant Opportunities for R&D
Initiatives 39
- Biotechnology Market in India on Growth Trajectory 40
- Market Participants 40
- Government Initiatives 40
- New Zealand 41
5. PRODUCT INTRODUCTIONS/INNOVATIONS 42
- Aqua Bio Technology Launches Zonase X Marine Ingredient 42
- Frutarom USA to Introduce New Range of Marine Extracts 42
- Biotech Marine Launches BioFA Anti-Aging Ingredient 42
6. RECENT INDUSTRY ACTIVITY 44
- Aqua Bio Technology Inks Supply Agreement with Bioforskning 44
- Aquapharm Biodiscovery Signs Licensing and Collaboration Agreement with
Croda 44
- AsiaPharm and GlycoMar Sign R&D Agreement 44
- Aquatic Eco-Systems Acquires Marine Biotech 44
- Dr. Reddy' s Laboratories and Aquapharm Biodiscovery Ink Licensing
Agreements 45
7. CORPORATE ACTIVITY IN RECENT PAST- A PERSPECTIVE BUILDER 46
- Aker BioMarine Merges with Natural ASA to Form Aker BioMarine 46
- Aker BioMarine Joins Hands with Pronova Biocare 46
- ABL Biotech to Establish New R&D Facility 46
- Aquapharm Strikes an Agreement with DowpharmaSM 46
- MMRC and Nereus Pharmaceuticals to Initiate Clinical Trials for NPI-0052 46
- CP Kelco Acquires Gold Millet 47
- Oman' s Attempt To Excel in Marine Research 47
- Marical Inks an Agreement with ACD 47
- PharmaMar Conducts Clinical Testing of Zalypsis (r) Anti-tumor Agent 47
- CP Kelco Merges with Noviant 48
- Marine Institute, Biotrove, and NUI' S Cooperative Research on Atlantic
Salmon 48
- Jinghua Marine Biological Merges with Work Recovery 48
- Albany Molecular Research and Alcon Research in Partnership 48
- Maryland-Israel Marine Biotechnology Research Program Gains Extension 48
- India to Set Up New National Institutions 49
- European Centre for Marine Biotechnology Inaugurated 49
- Diversa Collaborates with OSU 49
- PharmaMar Commences Phase I Clinical Trials of PM02734 49
- USFDA Confers Orphan Drug Status to PharmaMar' s Ovarian Cancer Drug,
YONDELIS(r) 49
- PharmaMar Undertakes Phase II Clinical Trials of Aplidin (r) for Bladder
and Prostate Cancers 50
- CorMatrix and Cook Biotech Enter into Research Agreement 50
- Elan Corp Receives European Approval for PRIALT(tm) (Ziconotide) 50
8. FOCUS ON SELECT PLAYERS 51
- Aker BioMarine ASA (Norway) 51
- CP Kelco US, Inc. (US) 51
- Cyanotech Corp. (US) 51
- Elan Corporation, plc (Ireland) 51
- FMC Corp. (US) 52
- FMC Biopolymers AS (Norway) 52
- GlycoMar Ltd. (UK) 52
- Integrin Advanced Biosystems (UK) 52
- International Specialty Products, Inc. (US) 53
- Lonza Group Ltd (Switzerland) 53
- MariCal (US) 53
- Marinova (Australia) 54
- Martek Biosciences Corp. (US) 54
- Mera Pharmaceuticals Inc (US) 54
- New England Biolabs Inc (US) 54
- PharmaMar S.A (Spain) 55
- PML Applications Ltd. (UK) 55
- Primex Ltd (Iceland) 55
- Prolume Ltd (US) 55
- Sea Run Holdings, Inc. (US) 56
- Tequesta Marine Biosciences (US) 56
9. GLOBAL MARKET PERSPECTIVE 57
- Table 1: World Recent Past, Current & Future Analysis for Marine
Biotechnology by Geographic Region - US and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009
through 2015 (includes corresponding Graph/Chart) 57
- Table 2: World Historic Review for Marine Biotechnology by Geographic
Region -US and Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) 58
- Table 3: World 11-Year Perspective for Marine Biotechnology by Geographic
Region- Percentage Breakdown of Dollar Sales for US and Rest of World Markets
for Years 2005, 2010 & 2015 58
- Table 4: World Recent Past, Current & Future Analysis for Marine
Biotechnology by Product Segment- Marine Biomaterials, Marine Bioactive
Substances, and Others Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2015 (includes corresponding
Graph/Chart) 59
- Table 5: World Historic Review for Mari1`ne Biotechnologyby Product
Segment - Marine Biomaterials, Marine Bioactive Substances, and Others Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003
through 2008 (includes corresponding Graph/Chart) 59
- Table 6: World 11-Year Perspective for Marine Biotechnology by Product
Segment- Percentage Breakdown of Dollar Salesfor Marine Biomaterials, Marine
Bioactive Substances and Other Markets for Years 2005, 2010 & 2015
(includes corresponding Graph/Chart) 60
- Table 7: World Recent Past, Current & Future Analysisfor Marine
Biotechnology by End-use Application-IndustrialProducts, Health
Care/Biotechnology, Consumer Products,Public Services and Infrastructure and
Other Markets Independently Analyzed with Annual Sales Figures in US$ Million
for Years 2009 through 2015 (includes corresponding Graph/Chart) 61
- Table 8: World Historic Review for Marine Biotechnology by End-Use
Application- Industrial Products, Health Care/Biotechnology, Consumer
Products, Public Services and Infrastructure and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008
(includes corresponding Graph/Chart) 62
- Table 9: World 11-Year Perspective for Marine Biotechnology by End-Use
Application- Percentage Breakdown of Dollar Sales for Industrial Products,
Health Care/ Biotechnology, Consumer Products, Public Services and
Infrastructure and Other Markets for Years 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 63
COMPETITIVE LANDSCAPE
|
 |
